Motor neuron involvement in a patient with long-term corticosteroid administration

Internal Medicine

Volumn 42, Issue 9, 2003, Pages 862-866

  Mitsui, Takao ^c   Umaki, Yoshifumi ^c   Nagasawa, Masakazu ^a   Akaike, Masashi ^c   Ohtsuka, Satoshi ^c   Odomi, Masaaki ^a   Aki, Kenji ^b   Matsumoto, Toshio ^c  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Asthma; Corticosteroid myopathy; Denervation; Mitochondria; Neurogenic muscular atrophy

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BETAMETHASONE; CELL NUCLEUS DNA; CORTICOSTEROID; LACTIC ACID; MITOCHONDRIAL DNA; UBIDECARENONE;

AGED; ARTICLE; ASTHMA; CASE REPORT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXERCISE TEST; HUMAN; HUMAN TISSUE; LACTATE BLOOD LEVEL; LIMB DISEASE; LONG TERM CARE; MALE; MOTOR NEURON DISEASE; MUSCLE ATROPHY; MUSCLE BIOPSY; MYOPATHY; TENDON REFLEX; TONGUE DISEASE;

EID: 0141927399     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.862     Document Type: Article

References (23)

1. Kaminski HJ, Ruff RF. Endocrine myopathies (hyper- and hypofunction of adrenal, thyroid, pituitary, and parathyroid glands and introgenic corticosteroid myopathy. in: Myology, 2nd ed. Engel AG and Franzini-Armstrong C, editors. McGraw-Hill, New York, 1994: 1726-1753.
2. Ansari KA. Steroids and motor nerve conduction velocity. Neurology 20: 396, 1970.
3. MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmatics. Lancet 2: 615, 1977.
4. Williams TJ, O'Hehir RE, Czarny D, Horne M, Bowes G. Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids. Am Rev Respir Dis 137: 460-463, 1988.
5. Danta G. Electrophysiological study of amyotrophy associated with acute asthma (asthmatic amyotrophy). J Neurol Neurosurg Psychiatry 38: 1016-1021, 1975.
6. 10 in Kearns-Sayre syndrome. Neurology 35: 372-377, 1985.
7. Mitsui T, Kawai H, Nagasawa M, et al. Oxidative damage to skeletal muscle DNA from patients with mitochondrial encephalomyopathies. J Neurol Sci 136: 111-116, 1996.
8. Mitsui T, Azuma H, Nagasawa M, et al. Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle. J Neurol 249: 1004-1009, 2002.
9. Mitsui T, Umaki Y, Nagasawa M, et al. Mitochondrial damage in patients with long-term corticosteroid therapy: development of oculoskeletal symptoms similar to mitochondrial disease. Acta Neuropathol (Berl) 104: 260-266, 2002.
10. Bindoff LA, Desnuelle C, Birch-Machin MA, et al. Multiple defects of the mitochondrial respiratory chain in a mitochondrial encephalopathy (MERRF): a clinical, biochemical and molecular study. J Neurol Sci 102: 17-24, 1991.
11. Kawai H, Akaike M, Yokoi K, et al. Mitochondrial encephalomyopathy with autosomal dominant inheritance: a clinical and genetic entity of mitochondrial diseases. Muscle Nerve 18: 753-760, 1995.
12. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 124 (Suppl): 96-107, 1994.
13. Windebank AJ, Mulder DW. Motor neuron disease in adults. in: Myology, 2nd ed. Engel AG and Franzini-Armstrong C, Eds. McGraw-Hill, New York, 1994: 1854-1869.
14. Ozawa T. Genetic and functional changes in mitochondria associated with aging. Physiol Rev 77: 425-464, 1997.
15. Engel AG. Electron microscopic observations in thyrotoxic and corticosteroid-induced myopathies. Mayo Clin Proc 41: 785-796, 1966.
16. Marolda M, Palma V, Camporeale FS. Steroid myopathy: clinical and immunohistochemical study of a case. Ital J Neurol Sci 12: 409-413, 1991.
17. Malandrini A, Scarpini C, Fabrizi GM, et al. Mitochondrial changes in myopathy with respiratory failure and rapid fatal course: report of a case. Eur Neurol 35: 182-183, 1995.
18. Umaki Y, Mitsui T, Endo I, Akaike M, Matsumoto T. Apoptosis-related changes in skeletal muscles of patients with mitochondrial diseases. Acta Neuropathol (Berl) 103: 163-170, 2002.
19. Yiannikas C, McLeod JG, Pollard JD, Baverstock J. Peripheral neuropathy associated with mitochondrial myopathy. Ann Neurol 20: 249-257, 1986.
20. Jinnai K, Yamada H, Kanda, et al. A case of mitochondrial myopathy, encephalopathy and lactic acidosis due to cytochrome c oxidase deficiency with neurogenic muscular changes. Eur Neurol 30: 56-60, 1990.
21. Siklos L, Engelhardt J, Harati Y, Smith RG, Joo F, Appel SH. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann Neurol 39: 203-216, 1996.
22. Borthwick GM, Johnson MA, Ince PG, Shaw PJ, Turnbull DM. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol 46: 787-790, 1999.
23. Comi GP, Bordoni A, Salani S, et al. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol 43: 110-116, 1998.